Pacific Biosciences of California (PACB) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Pacific Biosciences of California (PACB) has outperformed Viemed Healthcare (VMD) over the past year, gaining 52.3% versus a gain of 38.6%. Over five years, VMD leads with a +65.0% price change compared with -90.4% for PACB. Pacific Biosciences of California is the larger company by market cap ($724.2 million vs $362.6 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PACB | VMD |
|---|---|---|
| Share price | $2.33 | $9.52 |
| Market cap | $724.24M | $362.60M |
| 1-day change | +1.30% | +1.17% |
| YTD return | +24.60% | +28.13% |
| 1-year return | +52.29% | +38.57% |
| 5-year return | -90.45% | +64.99% |
| P/E ratio (TTM) | — | 26.44 |
| Forward P/E | — | 23.80 |
| EPS (TTM) | $-0.43 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.44 | $12.61 |
| 52-week low | $1.07 | $6.05 |
| Distance from 52-week high | -32.27% | -24.50% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +3.00% | +31.30% |
| Average volume | 10.48M | 353.27K |
| Shares outstanding | 310.83M | 38.09M |
| Employees | 485 | 1,438 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACB has outperformed VMD by 13.7 percentage points over the past year.
- The two companies sit in different sectors: Pacific Biosciences of California in Industrials and Viemed Healthcare in Health Care.
About Pacific Biosciences of California
PACB stock →Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
PACB vs VMD FAQ
Which is bigger, Pacific Biosciences of California or Viemed Healthcare?
Pacific Biosciences of California (PACB) is larger, with a market capitalization of $724.24M compared with $362.60M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, PACB or VMD?
PACB returned +52.29% over the past 12 months, compared with +38.57% for VMD (price return, excluding dividends). Past performance does not predict future results.
Are Pacific Biosciences of California and Viemed Healthcare in the same industry?
No. Pacific Biosciences of California is in the Industrials sector, while Viemed Healthcare is in Health Care.